| Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand … J Huang, D Liu, Y Wang, L Liu, J Li, J Yuan, Z Jiang, Z Jiang, WLW Hsiao, ... Gut 71 (4), 734-745, 2022 | 325 | 2022 |
| Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer ZB Jiang, WJ Wang, C Xu, YJ Xie, XR Wang, YZ Zhang, JM Huang, ... Cancer letters 515, 36-48, 2021 | 152 | 2021 |
| Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis ZB Jiang, JM Huang, YJ Xie, YZ Zhang, C Chang, HL Lai, W Wang, ... Journal of Experimental & Clinical Cancer Research 39, 1-16, 2020 | 87 | 2020 |
| Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling JX Li, RZ Li, A Sun, H Zhou, E Neher, JS Yang, JM Huang, YZ Zhang, ... Pharmacological research 171, 105574, 2021 | 59 | 2021 |
| Current clinical progress of PD-1/PD-L1 immunotherapy and potential combination treatment in non–small cell lung cancer JX Li, JM Huang, ZB Jiang, RZ Li, A Sun, E Lai-Han Leung, PY Yan Integrative Cancer Therapies 18, 1534735419890020, 2019 | 55 | 2019 |
| β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer C Xu, ZB Jiang, L Shao, ZM Zhao, XX Fan, X Sui, LL Yu, XR Wang, ... Pharmacological research 191, 106739, 2023 | 50 | 2023 |
| Identification of a novel protein arginine methyltransferase 5 inhibitor in non-small cell lung cancer by structure-based virtual screening Q Wang, J Xu, Y Li, J Huang, Z Jiang, Y Wang, L Liu, ELH Leung, X Yao Frontiers in pharmacology 9, 173, 2018 | 49 | 2018 |
| Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy J Huang, Z Jiang, Y Wang, X Fan, J Cai, X Yao, L Liu, J Huang, J He, ... Current Opinion in Pharmacology 54, 1-10, 2020 | 47 | 2020 |
| Identification of a new inhibitor of KRAS‐PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer ELH Leung, LX Luo, Y Li, ZQ Liu, LL Li, DF Shi, Y Xie, M Huang, LL Lu, ... International journal of cancer 145 (5), 1334-1345, 2019 | 44 | 2019 |
| Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti … X Fan, C Mai, L Zuo, J Huang, C Xie, Z Jiang, R Li, X Yao, X Fan, Q Wu, ... Acta Pharmaceutica Sinica B 13 (3), 1164-1179, 2023 | 34 | 2023 |
| Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway WJ Wang, LF Mao, HL Lai, YW Wang, ZB Jiang, W Li, JM Huang, YJ Xie, ... Pharmacological research 161, 105129, 2020 | 32 | 2020 |
| Extracellular vesicles as a novel mediator of interkingdom communication J Huang, X Wang, Z Wang, L Deng, Y Wang, Y Tang, L Luo, ELH Leung Cytokine & Growth Factor Reviews 73, 173-184, 2023 | 27 | 2023 |
| Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells ZB Jiang, C Xu, W Wang, YZ Zhang, JM Huang, YJ Xie, QQ Wang, XX Fan, ... Pharmacological Research 169, 105656, 2021 | 25 | 2021 |
| 中药提取新技术及其在国内的转化应用研究 王赛君， 伍振峰， 杨明， 王雅琪， 王芳， 柯刚， 黄居敏 中国中药杂志 39 (8), 1360-1367, 2014 | 18 | 2014 |
| Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharides J Zhang, J He, J Huang, X Li, X Fan, W Li, G Wu, C Xie, XX Fan, J Zhang, ... Biomedicine & Pharmacotherapy 162, 114610, 2023 | 16 | 2023 |
| Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism W Tian, J Huang, W Zhang, Y Wang, R Jin, H Guo, Y Tang, Y Wang, H Lai, ... Pharmacological Research 199, 107034, 2024 | 14 | 2024 |
| Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy ELH Leung, RZ Li, XX Fan, LY Wang, Y Wang, Z Jiang, J Huang, HD Pan, ... Nature Communications 14 (1), 5115, 2023 | 14 | 2023 |
| Bacteria-based nanodrug for anticancer therapy YJ Xie, M Huang, D Li, JC Hou, HH Liang, AA Nasim, JM Huang, C Xie, ... Pharmacological Research 182, 106282, 2022 | 14 | 2022 |
| Microbes mediated immunogenic cell death in cancer immunotherapy J Huang, F Duan, C Xie, J Xu, Y Zhang, Y Wang, YP Tang, ELH Leung Immunological Reviews 321 (1), 128-142, 2024 | 8 | 2024 |
| CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+ Tim3+ exhausted T cells in non-small cell lung cancer J Wang, RZ Li, WJ Wang, HD Pan, C Xie, LF Yau, XX Wang, WL Long, ... Pharmacological Research 194, 106850, 2023 | 8 | 2023 |